prevent hair loss on semaglutide GLP-1 Medications & Loss: What the Evidence Shows Wegovy Hair Loss: Causes &

Early clinical trials have shown that AOD 9604 effectively promotes fat loss without causing the significant side effects often associated with growth hormone therapy [1]

MOTS-c reliably activates this pathway

This is because: GLP-1 agonists: Slow gastric emptying, enhance insulin secretion, regulate hepatic glucose Amylin agonists: Suppress appetite centrally, slow gastric emptying via distinct pathways Together: Complementary mechanisms produce additive/synergistic effects on weight loss Cagrilintide Monotherapy Trials Initial clinical development focused on establishing the safety, tolerability, and efficacy of cagrilintide as a standalone therapy for weight management

Clinicians avoid prescribing GLP-1 agonists for individuals with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2A (MEN 2A), or type 2B (MEN 2B) (51)(53)

Yet the new benefit wont help the vast majority of the 1.5 million adults in South Carolina who are classified as obese, according to data published by the South Carolina Department of Public Health